Showing results (1311-1320 of 1,375) with videos related to
Sort By:
Pageof 138
Neurobiology of Disease|February 25, 2019
Assessment of APOE in atypical parkinsonism syndromesMarya S Sabir, Cornelis Blauwendraat, Sarah Ahmed, et al.Acta Neuropathologica Communications|April 27, 2021
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's diseaseJong-Sung Park, Tae-In Kam, Saebom Lee, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 18, 2021
Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's DiseaseNicole Mercado Fischer, Jared T Hinkle, Kate Perepezko, et al.Cell Reports|January 26, 2017
PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal SurvivalYunjong Lee, Daniel A Stevens, Sung-Ung Kang, et al.The Journal of Clinical Investigation|April 15, 2025
Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson's disease severityKelly A Mills, Yong Du, Jennifer M Coughlin, et al.EMBO Reports|July 12, 2015
(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylationFabienne C Fiesel, Maya Ando, Roman Hudec, et al.Plos One|April 16, 2011
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2David Ramonet, João Paulo L Daher, Brian M Lin, et al.Parkinsonism & Related Disorders|September 25, 2021
Seeking progress in disease modification in Parkinson diseaseCodrin Lungu, Jesse M Cedarbaum, Ted M Dawson, et al.Nature|June 22, 2017
T cells from patients with Parkinson's disease recognize α-synuclein peptidesDavid Sulzer, Roy N Alcalay, Francesca Garretti, et al.Nature|September 15, 2017
Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptidesDavid Sulzer, Roy N Alcalay, Francesca Garretti, et al.Pageof 138